APOE and Alzheimer disease: Of interest, findings from sensitivity analyses suggest that this contribution would be more pronounced in the early stages of the disease process (CDR = 0) or in the absence of a well-established risk factor of AD such as APOE ε4 allele (eMethods—sensitivity analyses), where the AD cascade might not be driven by amyloid and vascular risk factors might be more relevant.